| |
|
| |
 |
From last year
(December 6, 2006) |
|
|
|
|
Becky Bergman
Vice President
Science & Technology
Medtronic |
|
Becky Bergman joined
Medtronic 17 years ago, and has been a leader in
the advancement of biologically oriented sciences
at Medtronic. She is currently Vice President, Science & Technology,
with responsibility for Medtronic’s Materials
and Biosciences Center, the Technical Knowledge Center,
innovation programs, and other corporate technology
initiatives. Prior to this job, Becky held scientific
and R&D management positions of increasing responsibility
within the corporation. She has received several
of Medtronic’s highest honors. This includes
membership in the Bakken Society, an honorary society
for Medtronic’s most distinguished scientific
and technical contributors, and recipient of the
Wallin Leadership Award, which recognizes outstanding
leadership at Medtronic. In 2000, Becky played a
key role in development of Medtronic’s “Vision
2010,” a 10-year strategic plan for the corporation.
Since that time Becky has been a leader in technology
strategic planning and execution of new corporate
R&D initiatives.
Becky holds a B.S. degree
in Chemical Engineering from Princeton University,
and she has completed graduate studies in Chemical
Engineering and Materials Science at the University
of Minnesota. She has served as an Adjunct Professor
at the University of Minnesota, and has taught Biomedical
Engineering courses there. Becky is a Fellow of the
American Institute for Medical and Biological Engineering.
She recently served on the Committee on Engineering
and the Health Care System that developed a report
from the National Academy of Engineering and Institute
of Medicine of the National Academies entitled, “Building
a Better Delivery System: A New Engineering / Health
Care Partnership”. |
|
|
|
Doug Cameron
Chief Scientific
Officer
Khosla Ventures
|
|
Doug Cameron grew
up in the Chicago suburbs where he developed a passion
for science and technology by visiting Chicago's zoos
and science museums. Doug attended Duke University,
where he majored in biomedical engineering--the broadest
and most interdisciplinary major he could find--and
graduated magna cum laude.
Doug's first job after college
was with a new start-up company called Advanced Harvesting
Systems (AHS), funded by International Harvester,
where he was the first non-founding employee. The
goal of the company was to design and build a protein-harvesting
combine, dubbed "the Probine." Doug helped
the company grow from four people in 1979 to over
thirty in 1981. He also helped build two agricultural
laboratories, one in Tempe, Arizona and one in El
Centro, California. The company, however, was more
than twenty years ahead of its time and didn't last
beyond 1982. Nevertheless, this first experience
gave Doug a lasting appreciation and fascination
with entrepreneurship.
While at AHS, Doug followed
the October 14, 1980 Genentech IPO and could hardly
wait to go to graduate school to study genetic engineering
and become part of the biotechnology revolution.
He started at MIT in July, 1981 and graduated with
a Ph.D. in biochemical engineering in 1986. His thesis,
under the direction of Charles Cooney, was on the
metabolism of a thermophilic anaerobic bacterium
that produces ethanol and other chemicals. Doug also
maintained his interest in business; one of his most
memorable classes was "The Management of Technology" taught
by Tom Allen in the MIT Sloan School.
Although Doug was open to
an industrial position, he couldn't resist an offer
to join the faculty of the Department of Chemical
Engineering at the University of Wisconsin, Madison,
one of the top departments in the world. Doug taught
biochemical engineering, as well as many of the core
chemical engineering subjects. He established a research
program in metabolic engineering and was a pioneer
in its application to industrial chemicals, including
1,3-propanediol and 3-hydroxypropionic acid. While
at Wisconsin, Doug was tenured and promoted to full
professor. He took a sabbatical in the Institute
for Biotechnology at the ETH in Switzerland.
He was also on the scientific advisory board of two
start-up companies and consulted for DuPont, Genencor
and Cargill.
In 1998, Doug was recruited
to start and lead the Cargill corporate biotechnology
R&D group, now called the Biotechnology Development
Center (BioTDC), in Minneapolis, Minnesota. The group
developed a diverse range of processes and technologies
involving enzymes and microorganisms for the production
of food, animal feed, fuel and industrial products.
While at Cargill, Doug maintained a close relationship
with the (renamed) Department of Chemical and Biological
Engineering in Madison and also became a consulting
professor in the Department of Chemical Engineering
at Stanford University. |
|
|
|
Thomas
Gunderson
Senior Research
Analyst
Piper Jaffray |
|
Thomas
Gunderson is a managing director and senior
research analyst at Piper Jaffray, following cardiology
and other medical device companies. Gunderson was
named a Wall Street Journal All-Star Analyst for
medical stocks in 1996 and 2000. Gunderson holds
a bachelor's degree from Carleton College, a master's
degree in cell biology from the University of Minnesota,
and a master's degree in business administration
from the University of St. Thomas. |
|
|
Dr. Leroy Hood
President
Institute for Systems Biology
M.D., Johns Hopkins School
of Medicine, 1964
Ph.D., Biochemistry, California Institute of Technology, 1968 |
|
Dr.
Leroy Hood is recognized as one of the
world's leading scientists in molecular biotechnology
and genomics and is widely considered “the
father of Systems Biology.” A passionate
and dedicated researcher, he holds numerous patents
and awards for his scientific breakthroughs and
prides himself on his life-long commitment to making
science accessible and understandable to the general
public, especially children.
In 2000, Dr. Hood co-founded the Institute for Systems Biology
in Seattle, Washington to pioneer systems approaches to biology
and medicine. He serves as President of the Institute and continues
to pursue his interest in biology, medicine, technology, development,
and computational biology. His pioneering work to pull together
these diverse technologies has the aim of revolutionizing health
care in terms of diagnostics, therapy and ultimately prevention
of disease.
Over the course of his career, Dr. Hood has played a role in founding
several biotechnology companies, including Amgen, Applied Biosystems,
Systemix, Darwin, Rosetta, and MacroGenics, having earned an M.D.
from Johns Hopkins University in 1964 and a Ph.D. in biochemistry
from the California Institute of Technology in 1968. Hood has published
more than 600 peer-reviewed papers and co-authored textbooks in
biochemistry, immunology, molecular biology and genetics. He also
co-edited "Code of Codes," a book discussing scientific,
social and ethical issues raised by genetic research. His
professional career began at Caltech, where he and colleagues pioneered,
the DNA and protein synthesizers and sequencers that constitute
the technological foundation for contemporary molecular biology
and that have revolutionized genomics by allowing the rapid automated
sequencing of DNA. An early advocate of the Human Genome Project,
he also played a pioneering role in deciphering the secrets of
antibody diversity.
Dr. Hood is a member of
the National Academy of Sciences, the American Philosophical
Society, and the American Association of Arts and Sciences.
His many awards and honors include the Lasker Award
in 1987 for studies on the mechanism of immune diversity,
the Kyoto Prize for Advanced Technology in 2002, and
the Lemelson-MIT Prize for Invention and Innovation
in 2003. One of his foremost goals is bringing
hands-on, inquiry-based science to K-12 classrooms. |
|
| |
|
|
Lonnie Moulder
President & CEO
MGI PHARMA |
|
Lonnie
Moulder has served as President and CEO
of MGI PHARMA since 2003. He joined MGI PHARMA
in 1999 as Executive Vice President and assumed
the role of President and Chief Operating Officer
in May 2002. Prior to joining MGI PHARMA, he was
part of the founding management team and Vice President,
Business Development and Commercial Affairs, of
Eligix, Inc., a venture-stage biomedical company
that was based in Boston, MA. This followed 16
years of various commercial roles with Hoechst
Marion Roussel (now Sanofi Aventis) and its predecessor
companies, Marion Laboratories and Marion Merrell
Dow. Mr. Moulder’s tenure at HMR culminated
as Product Group Director, Oncology and Anti-Infective
Products. He currently serves as a board of director
for Methylgene, Inc. and Medical Alley/MNBIO. Mr.
Moulder received a BS in pharmacy from Temple University
in 1980 and began his career as a clinical pharmacist.
He also holds a MBA from the University of Chicago. |
|
|
|
Susan Paquette
Commercialization
Director
3M Health Care
Business |
|
Susan
Paquette has 25 years of experience related
to new product commercialization at 3M. She is
currently Commercialization Director, for 3M Health
Care which encompasses new product commercialization,
technology licensing/acquisition and university
relations. Susan has a broad background with experience
in business development, product development, laboratory
management, market development and manufacturing
support. She has worked in a variety of businesses
while at 3M including the Health Care Business,
Medical Division, Automotive Aftermarket Division
and Commercial Graphics Division. Susan graduated
from the University of Kansas with a B.S. in Chemical
Engineering and obtained an M.B.A. from the University
of St. Thomas. She is currently pursuing a Master's
in Physiology from the University of Minnesota
which she hopes to complete by year end. |
|
|
| |
| Seminar
Session Presenters From last year
(December 6, 2006) |
|
| |
|
Elizabeth
Abraham, CEO, Top Tool Corporation Seminar
205 |
| Elizabeth
is the majority owner, CEO, and Treasurer of Top
Tool Company, a precision manufacturing and metal
stamping company. Elizabeth has a background in small
business consulting, a Senior Strategic Planner at
First Bank Minneapolis, and a financial analyst for
Corporate Long Range Planning and Strategic Development
at the Pillsbury Company. She received her
MBA (Finance) from the University of Minnesota. Elizabeth
taught Marketing at St. Thomas University,
and Small Business Management at the Carlson School
of Management. Prior to entering the business field,
Elizabeth worked in the field of mental health, at
the Psychology Department at Fox River Hospital
in Chicago, taught medical students and physicians
at the Chicago Medical School,
and started a consulting practice in Evanston, Ill.
In addition, Elizabeth is an instrument rated private
pilot, owns a Mooney, and frequently flies to Nebraska
and Maine. |
|
|
| Aron
B. Anderson, Ph.D., Vice President, Chief Scientific
Officer, SurModics Seminar
104 |
Aron
Anderson, Ph.D. is currently Chief Scientific
Officer at SurModics. Aron has worked at SurModics
since 1991, where he has contributed to the development
of technology for blood-compatible coatings and drug
delivery platforms. Dr. Anderson also serves on the
Board of Directors of University Enterprise Laboratories,
a partnership between the University of Minnesota,
the city of St. Paul, and local industry that functions
as a technology company incubator. Aron
received a B.S. in Chemical Engineering from the University
of Minnesota in 1985. He received his M.S.
in 1987 and Ph.D. in 1991, both in Chemical Engineering
from Stanford University . |
|
|
Paul
Brooks, Vice President, BSI Americas Seminar
202 |
Paul
qualified as a technician-engineer at BSI Testing Laboratories.
In 1993 Paul joined BSI Inc. the US subsidiary of BSI,
as the local expert on CE Marking under the Medical
Devices Directive. In 1998 he returned to London 1998
to be Head of Notified Body for BSI’s Medical
Devices Group, and was regularly involved in European
Medical Devices Notified Bodies meetings. Today Paul
is once again located in BSI’s Washington DC
office and is responsible for leading BSI activities
in the medical devices sector including Notified Body.Paul
is a member of the American Society for Quality and
Regulatory Affairs Professional Society. |
|
|
| Thomas
W. Burns, Technical Support Manger, Medical Molding & Assembly,
Phillips Plastics Corporation Seminar
105 |
| Thomas
Burns is the Technical Support Manager at Phillips
Plastics Medical Molding and Assembly facility in Menomonie,
Wisconsin. His career with Phillips Plastics began
at the Insert Molding facility as a Senior Process
Engineer. In his current role, Tom provides technical
leadership and the integration of maintenance,
manufacturing and process engineering in addition
to driving Lean Manufacturing initiatives. Tom has
been with Phillips Plastics for 7 years. Tom has
worked in variety of manufacturing environments, from
high volume clean room molding to lower volume "job
shop" environments and been challenged with
applying Lean tools appropriately to unique
production applications. Tom holds an Associate
of Science degree in Electromechanical Technology,
a Bachelors Degree in Business Administration, and
certification in Lean Manufacturing from the Northwest
Wisconsin Manufacturing Outreach Center (NWMOC). |
|
|
| Michael
Chambers, President and Chief Financial Officer,
Aldevron Seminar
107 |
| Michael
Chambers is the President and CEO of Aldevron (Fargo, ND).
Aldevron provides contract biological manufacturing
services for research groups in academia, government
and industry. The company specializes in plasmid DNA
production for preclinical, clinical and diagnostic
applications. In 2003, Aldevron manufactured the world’s
first DNA vaccine to be used outside of a clinical
setting. In 2004, the Company acquired GENOVAC, a German
antibody company. Chambers founded Aldevron in 1998
after graduating from North
Dakota State University.
In addition to Aldevron, he servers on several NDSU
boards and is a director of the biotech company ADViSYS
(The Woodlands, TX). |
|
|
| Kathy
M Cooney, Executive Vice President and Chief Administrative
Officer, HealthPartners Seminar
106 |
| Kathy
Cooney is executive vice president and chief administrative
officer for HealthPartners. She is also the chief
financial officer. She is responsible for areas
related to information services & technology, human
resources, dental administration, finance, actuarial/underwriting,
health plan operations, and government programs. Ms.
Cooney came to HealthPartners in 1986 from Ernst and
Whinney (now Ernst and Young), where she served as
a management consultant specializing in health care
strategies. Ms. Cooney has held many positions
at HealthPartners, including vice president of clinic
operations, vice president of administration and continuous
quality improvement support, and senior director of
corporate staff. Ms. Cooney received her nursing degree
from Northern Illinois University. She
received a master’s degree in business administration
from Northwestern University. |
|
|
| Sue
Danielson, RAC Regulatory Affairs / Quality Director
Medical/Surgical Division, 3M Seminar
102 |
| Sue
Danielson is a Regulatory Affairs and Quality Director
at 3M Company. She has worked in the health care
industry for over 20 years in the areas of regulatory
affairs, quality and clinical research. In her
current position within 3M’s Medical Division,
Sue has the global leadership role for regulatory affairs,
quality and compliance. She has experience working
with a broad range of medical devices, topical antimicrobial
drug products and cosmetic products marketed to both
health care professionals and consumers. Sue
earned her Bachelor’s degree from the University of Minnesota, School of Public
Health. |
|
|
| Wally
Danielson, Chief Executive Officer and Founder, ImPres
Medical, Inc. Seminar
207 |
| Wally
Danielson has 20 years of experience in the medical
industry as an entrepreneur, owner, founder and executive.
He became CEO of Impres Medical in May 2000. Prior
to joining Impres, Mr. Danielson was an angel investor
and VP of Sales and Marketing at Promethean Medical,
a start-up focused in gynecology and urology. At
Ferring Pharmaceuticals he helped introduce a new infertility
injectable into the United States Ob/Gyn and fertility
market from 1997-1999. He was President and CEO of
Spectrum Medical Inc., an orthopedic implant distributorship,
from 1990-1997. In 1996 he was a Founder of Northstar
Medical. In his early career, he was a Sales Representative
for a start-up orthopedic implant manufacturer Orthomet
, and for Pfizer Pharmaceutical. Mr. Danielson
received a BS in Chemistry and Business from the University
of Wisconsin-Eau Claire. |
|
|
Diane
Davies, MD, Consultant, University of Minnesota Seminar
305 |
| Currently
Diane is completing postdoctoral training in Health
Informatics at the University of Minnesota.
Her primary goal is to translate informatics research
into tools which can be used in everyday life such
as personal health records, telemedicine, and disease
management to improve the access to and quality of
care patients receive. During the past eighteen years
she has worked with medical device companies, venture
capital firms and pharmaceutical companies in various
capacities including clinical trials, new business
development, outcomes, product marketing, strategic
planning and consulting. Most recently she worked with
Fortune 500 companies, medical caregivers, and health
plans to increase the quality of care and decrease
the costs. |
|
|
| Laura
Dierker, Market Segment Manager - Life Sciences,
Sciemetric Seminar
307 |
| Laura
has served as Sciemetric Instruments Marketing Manager
for Life Sciences since 2004, adapting the Canadian
firm’s strengths in the automotive industry to
the medical device manufacturing arena. Much of this
work has been focused on developing relationships with
companies in the Minneapolis/St. Paul med-tech cluster,
understanding their processes and identifying their
needs. Prior to Sciemetric, Laura was President
of a small telematics technology firm in Ottawa, Ontario.
She has spent 13 years in the telecommunications industry
in various positions that have included product management,
marketing and general management. Laura started her
professional life as a violinist in a café orchestra
in Freudenstadt; West Germany. Laura received
a Master’s in Business Administration from the
Richard Ivey School of Business in London Ontario,
and a B.Sc. in Physics from the University of Waterloo
in Waterloo Ontario,
Canada. In 1996 she was awarded the Canadian Women
in Communications ‘Trailblazer of the Year’ award
for the introduction of Canada’s first internet
based Virtual Private Network while at iSTAR iNTERNET.
In 1998, Laura was awarded the Nortel Networks Systems
Engineering Core Inaugural Award for Excellence in
New Business Starts. |
|
|
| Randall
Doyal, Chief Executive Officer, Al-Corn Clean Fuels Seminar
101 |
| Randall
J Doyal is a 20+ year veteran of the fuel ethanol industry,
beginning his career in ethanol in 1982 with Mountain
Development Corporation as a cooker and continuing
on to his current position as General Manager and CEO
of Al-Corn Clean Fuel and Al-Corn Limited Partnership
in Claremont, Minnesota. Besides lobbying for
ethanol concerns, Randall serves on many industry related
boards including the board of the Renewable Fuels Association,
secretary for the Minnesota Coalition for Ethanol,
and President of the Midwest Distillers Grains Association. He
is also one of the founding governors of Renewable
Products Marketing Group, an ethanol marketing cooperative
that combines the ethanol production of several Midwestern
ethanol plants into a powerful marketing alliance. |
|
|
| Peter
Ekberg, Partner and Co-Chair of Emerging Companies
Practice, Faegre & Benson LLP Seminar
201 |
| Peter
is the Co-Chair of the Firm’s Emerging Companies
Practice, one of the leaders of Faegre’s Renewable
Fuels Group and a partner in the Firm’s corporate
group. As Co-Chair of the Firm’s Emerging
Companies Practice, Peter works with a variety of businesses,
including medical device, biotech, ethanol and technology-related
growth companies. Peter has significant experience
in a wide variety of complex corporation transactions,
including mergers and acquisitions, public and private
securities offering, project finance and joint ventures. Peter
graduated from the Columbia Law School,
where he was Editor-In-Chief of the Columbia Journal
of Transnational Law, and the United
States Military Academy at West
Point,
after which he received a commission as an officer
in the United States Armored Cavalry, serving in both Europe and
in combat operations during Operation Desert Strom . |
|
|
| Robert
Elde, Ph.D., Dean, College of Biological Sciences,
University of Minnesota Seminar
101 |
Robert
Elde is dean of the University of Minnesota’s College of Biological
Sciences and
Chair of the Executive Committee for the Initiative
for Renewable Energy and the Environment (IREE).
IREE, funded by the Minnesota Legislature, supports
development of alternative energy from hydrogen,
biomass, wind and sun. Dr. Elde is also Chairman
of University Enterprise Laboratories, a nonprofit
incubator that supports early-stage bioscience
companies. He is professor of neuroscience and
holds an honorary medical degree from the Karolinska
Institute. Among his accomplishments, he has created
Biodale, a “shopping mall” of advanced
research services available to local companies
as well as faculty and students. |
|
|
| Heidi
Emanuael, Director of Strategy & Innovation,
Research & Dvelopment, General Mills, Inc. Seminar
304 |
Heidi
has worked for General Mills for the past 17 years
and has become a specialist in new product opportunity
identification. She leads a team of internal
consultants who facilitate new product teams during
the discovery phase of new product development. The
goal for this service is to “systematize” innovation,
making successful opportunity identification less
haphazard and more repeatable. Heidi has an undergraduate
degree in Nutrition, and a graduate degree in Food
Science. She has spent most of her career
working in the food industry on products that span
the grocery store.
|
|
|
| David
M. Frazee, Technical Director, 3M Corporate Research
- SEMS Laboratory Seminar
305 |
| David
Frazee is the Technical Director of the Software, Electronic & Mechanical
Systems (SEMS) Research Laboratory at 3M in St.
Paul, MN.
He has previously held senior management positions
at GE Medical Systems, Vital Images, Inc. and Ingenix.
Early in his career, he was a design and systems engineer,
working on software and advanced technology for CT
and 3D medical imaging. He holds a BSEE from SDSU and
a MSEE/CS from Marquette University. |
|
|
Wayne
Freese, DVM, MS, CEO & Chariman ,
Prairie Holdings Group and Newport Laboratories
Seminar
306 |
| Practicing
veterinarian for 28 years and co-owner of the Veterinary Medical Center
in Worthington, MN. In 1981, co-founded Oxford
Laboratories. In 1994, founded Newport Laboratories
which provides veterinary diagnostics and biologics
in the United States and internationally. Co-founder,
CEO/Chairman of Prairie Holdings Group which encompasses
8 companies in the agribusiness/animal health industry
and employs 200 people. Board member of the Swine Disease Eradication Center
at the University of Minnesota. Served as a consulting
veterinarian in Europe, Asia, Mexico, and Canada. Past
President of the American Association of Swine Practitioners
and the Interstate Veterinary Medical Association.
Served on Worthington Economic planning board; City
of Worthington committees; bank director; church council
chairman, finance chairman, and building co-chair. Trustee
of the Southwest Minnesota Foundation. |
|
|
| Phil
Gerlach, Senior Director of Manufacturing Services, PDL BioPharma Seminar
306 |
| Phil
Gerlach has served in a number of engineering and manufacturing
positions at PDL BioPharma
since 1995. As Senior Director of Manufacturing
Services, Mr. Gerlach is responsible for the engineering,
technical services, metrology, facilities, and EH&S
operations. From 1990 to 1995, he worked in various
engineering, manufacturing, and management capacities
at Helix Biocore and Lifecore Biomedical. Mr.
Gerlach also held positions in quality assurance and
chemical engineering at the Gillette Company and performed
biochemical research at the University of Minnesota. He
received a Bachelor of Science degree in Biochemistry
and a Bachelor of Chemical Engineering degree from
the University of Minnesota. |
|
|
| Phil
Goldman, J.D., Fredrikson & Byron, P.A. Seminar
204 |
| Phil
joined Fredrikson & Byron’s Intellectual
Property Group in 1992, after serving for 10 years
in 3M’s Office of Intellectual Property Counsel.
He holds a B.S. in Biochemistry, an M.S. in Microbiology,
has completed pre-doctoral work in Radiation and Molecular
Biology has worked as a research biochemist. Phil’s
intellectual property experience includes all aspects
of U.S. and
international work relating to the health, animal,
and agricultural industries, with a particular focus
on biomedical devices and biologics. He is also active
in the firm’s technology transfer, intellectual
property litigation, and mediation practice areas. |
|
|
Peter
L. Gove, Retired, St. Jude Medical Executive Seminar
106 |
| Peter
Gove was vice president of Corporate Relations and
a corporate officer at St. Jude Medical from 1994 to
2005. His responsibilities included corporate
communications, U.S. and
international public policy and government relations. He
was St. Jude’s liaison with the University and
AdvaMed, served on the Medical Alley board and a founding
director of the Medical Technology Leadership Forum. Prior
to joining SJM,
Peter held executive positions with Control Data Corporation.
He also devoted a decade to public service for the
State of Minnesota and U.S. government. Peter
is on the board of directors of two Minnesota medical
technology companies and three nonprofits. He co-chaired
the recent Citizens League Medical Facilities Study
Committee. |
|
|
| Rod
Greder, Ph.D., New Productivity Group, LLC Seminar
104 |
| Rod
Greder, Ph.D. is an international trainer and consultant
in new product development. Earlier in his career,
he was engaged in a ground-breaking convergence project
at Dow Chemical to produce recombinant proteins with
therapeutic properties in plants. Currently, he serves
on the board of the Product Development & Management
Association of Minnesota, is co-chair of the R&D
SIG of Life Science Alley, writes a column on product
development for Manufacturer’s Alliance and
teaches new products management in the MBA program
at the University of St.
Thomas.
He also facilitates a monthly forum for leaders of
product development and management that focuses on
best practices, benchmarking and breakthrough insights. |
|
|
| Ames Gross,
President and Founder, Pacific Bridge Medical Seminar
302 |
| Mr.
Gross is recognized nationally and internationally
as a leader in the Asian medical markets. Mr. Gross
founded PBM in 1988 and has helped over 200 medical
companies with business development and regulatory
issues in Asia.
Mr. Gross is a frequent contributor of articles on
Asian medical issues for Clinica (England),
Medical Device and Diagnostic Industry (Los
Angeles),
and other medically oriented journals. Mr. Gross has
been a featured speaker on the Asian medical markets
at the Medical Design and Manufacturing shows, the
Medtrade Home Health Care Exhibition, the Regulatory
Affairs Professional Society’s annual and regional
meetings, and a variety of other medically oriented
meetings and conferences. Prior to establishing PBM,
Mr. Gross gained broad experience, knowledge and contacts
in Asia while
working at three major Wall Street firms. Mr. Gross
has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and
an MBA from Columbia University. |
|
|
| Beth
Hahn, PhD, Managing Director United BioSource Corporation Center for
Pricing & Reimbursement Seminar
303 |
Dr.
Hahn’s expertise is in health outcomes research
and reimbursement. Her work with biotech,
device and pharmaceuticals manufacturers includes
providing payer-focused review of protocol designs
against criteria for coverage to assess the potential
for reimbursement for products in development. She
has provided guidance to manufacturers on the FDA
and CMS interactions
to prepare for simultaneous launch to both agencies. Dr.
Hahn has 10 years with GlaxoSmithKline and 4 years
with the Agency for Health Policy and Research. Dr.
Hahn received her Ph.D. from the University of Illinois |
|
|
| Bonnie
Handke, R.N., Senior Manager, Health Policy & Payment,
Metronic Inc. Seminar
303 |
| Bonnie
Handke is a Senior Manager in Corporate Health Policy
and Payment at Medtronic, Inc., the world leader in
medical technology providing lifelong solutions for
people with chronic disease. In this role, she develops
coverage and reimbursement strategies for Medtronic
products and therapies. She has successfully
achieved local and national coverage policies as well
as payment and coding improvements for new technologies.
Prior to joining Medtronic in 1999, Bonnie spent 6 ½ years
at Medica Health Plans, a large Minnesota HMO and PPO,
where she was responsible for negotiating and implementing
physician and ancillary provider contracts and has
experience in case management and benefit review. Bonnie
received her B.A. in Management and Communications
from Concordia University,
and is a Registered Nurse. She is currently pursuing
an MBA at St.
Thomas University. |
|
|
| Robert
Hansen, Co-Founder, Chairman and Chief Executive
Officer, Electromed Seminar
207 |
| Robert
Hansen co-founded Electromed, Inc. in 1992. The Company
has developed the SmartVest Airway Clearance System. “Bob” is
responsible for the strategic direction, planning,
financing and development of the Company. He has been
a principal in several entrepreneurial ventures resulting
in the issuance of more than 50 patents. Bob has been
responsible for initiating and completing more than
fifteen private placements aggregating greater than
$10 million dollars among five companies. Only one
involved an investment banker He holds a B.A. Degree
from Dana College and
advanced degrees from the University of Cincinnati, University of St.
Thomas,
and Luther Theological Seminary. |
|
|
| Jacquie
Hart, New Product Development Manager, Smead Seminar 105 |
| Jacquie
Dutton Hart is New Product Development Manager for
Smead, an innovative manufacturer of organizational
products. She is naturally right-brained--generating
an average of more than 100 new product pipeline ideas
a year—yet has trained in disciplines such as
Six Sigma and Corporate Finance, which have enabled
her to be successful in adapting her ideas to a left-brain
business world. In her work at Smead, Jacquie
is developing expertise in the unique organizational
needs of visually-oriented, creative personalities.
Jacquie holds an MBA in Finance from New
York University and
is a former Business Development Manager for Imation. |
|
|
| Judith
Hickey, MBA, President, Princeton Reimbursement Group Seminar
303 |
| Ms.
Hickey is the founder and President of Princeton Reimbursement
Group, a reimbursement consulting firm focused on medical
products, located in Minneapolis, Minnesota. Ms
Hickey is an experienced medical marketing executive
and expert in medical product reimbursement. She has
been responsible for the development and execution
of reimbursement strategic plans, market positioning
strategies, and policy analysis for medical products
manufacturers throughout the U.S. and Europe. Prior
to the formation of PRG in 1991, Ms. Hickey’s
background included positions in marketing management
and reimbursement for medical product companies, including
Medtronic and Datascope. In addition to consulting,
Ms. Hickey is a faculty member of the Heart Rhythm
Society (HRS),
a medical specialty group representing more than 3700
specialists in cardiac pacing and electrophysiology
in 64 countries, and has served as co-chairman of the
Reimbursement Special Interest Group for LifeScience
AIIeyTM. She has written numerous published articles
on reimbursement issues and is a sought after speaker
on various reimbursement related topics. Ms. Hickey
is also a lecturer at Stanford University, University of California,
the University of Minnesota’s
Carlson School of Management, and the University of St.
Thomas.
She holds a BSBA degree in Marketing from the University of Missouri and
MBA Degree from the University of St.
Thomas, St.
Paul, Minnesota. |
|
|
Gayle
Johnson, Manager International Regulatory Affairs,
Guidant/Boston Scientific Seminar202 |
| Gayle
Johnson is manager of International Regulatory Affairs
for Boston Scientific CRM (formerly Guidant Corporation.)
Gayle has over 25 years experience in the areas of
Compliance and Regulatory Affairs. Her experience includes
management of the special biologics and tissue transplant
departments at American Red Cross,as well as management
of technical services and clinical study compliance
at Haemonetic's Corporation. In her current role, Gayle
manages all facets of market approval and postmarket
activities for 126 international markets. She has held
this position for the last 10 years. Gayle has degrees
in nursing and training and development. she is also
an instructor on Regulatory Affairs at UST and U of
M Biomedical Engineering School. |
|
|
| B.
Kristine Johnson, Managing Partner, Affinity Capital Seminar
207 |
| Kris
Johnson is a Managing Partner at Affinity Capital,
a venture capital firm that invests in private, U.S.-based
health care companies. Prior to joining Affinity Capital,
Johnson was most recently senior vice president and
chief administrative officer of Medtronic. During her
17 years at Medtronic she was also president and general
manager of Medtronic's Vascular business and of its
Tachyarrhythmia Management business. Prior to Medtronic,
she spent nine years in various executive positions
at Cargill. She serves on the boards of directors
of CoAxia, LifeSync, Otologics, Transoma and Piper
Jaffray Companies. |
|
|
| Joel
Jorgenson, Chief Executive Officer, Packet Digital Seminar
305 |
| Dr.
Joel Jorgenson is CEO & President of Packet Digital
LLC in Fargo, ND.
He is leading groundbreaking research in advanced po | | | |
